Embecta forecasts $1.80-$1.90 FY2026 adjusted EPS while raising adjusted operating margin to 23.5%-24% (NASDAQ:EMBC)

Embecta (EMBC) Q3 FY2026 earnings call recap: revenue rebound, Owen Mumford integration, raised EPS/margin guidance, and risks.

Embecta forecasts $1.80-$1.90 FY2026 adjusted EPS while raising adjusted operating margin to 23.5%-24% (NASDAQ:EMBC) | Seeking Alpha

Earnings Call Insights: Embecta (EMBC) Q3 fiscal 2026

Management View

"During the third quarter, Embecta generated total revenue of approximately $272 million" and "on a sequential basis, our third quarter financial performance improved significantly with revenue increasing approximately $50 million" (President, CEO & Chairman Devdatt Kurdikar).

Seeking Alpha's Disclaimer:

This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please

report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search field

Entering text into the input field will update the search result below

Quick Insights

How did Embecta's Q3 results compare to prior quarters?

Q3 showed sequential improvement in revenue and profit versus Q2, with management emphasizing a shift from prior quarter difficulties to a quarter of solid progress and completed integration steps after the Owen Mumford acquisition.

What is Embecta's outlook and guidance following Q3 performance?

Management reaffirmed full-year revenue guidance, raised adjusted operating margin and adjusted EPS guidance due to cost controls, and noted capital allocation will focus on debt repayment.

What are the main competitive and market risks highlighted in the earnings call?

Key risks include pricing and mix pressure in the U.S., ongoing monitoring of U.S. market volume affected by insured trends and GLP-1 therapies, plus execution risk for the Owen Mumford integration.

Recommended For You

More

Trending News

See More

»